Notification from Sopharma AD under Art. 19 of Regulation (EU) No 596/2014 of September, 10 2018
English
Sopharma AD notifies that for August 2018 the Company recorded an increase of sales revenues of 11% compared to the same month of 2017, including 7% decrease of domestic sales and an increase of 25% of export sales.
For the first eight months of this year, revenues from sales of products decreased by 4% compared to the same period of 2017, including 5% decrease of domestic sales and 3% decrease of export sales.